BLRX BioLineRX Ltd. ADRs

BioLine Rx Ltd is a clinical stage biopharmaceutical development company engaged in identifying, in-licensing & developing therapeutic compounds. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:BLRX.

$0.88  -0.07 (-7.51%)
As of 09/26/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  07/25/2011
Outstanding shares:  47,885,578
Average volume:  516,976
Market cap:   $45,299,757
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.71
PS ratio:   0.00
Return on equity:   -34.37%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy